Intelicare Holdings Limited

ASX:ICR Stock Report

Market Cap: AU$2.6m

Intelicare Holdings Past Earnings Performance

Past criteria checks 0/6

Intelicare Holdings's earnings have been declining at an average annual rate of -7.8%, while the Healthcare Services industry saw earnings growing at 14.3% annually. Revenues have been declining at an average rate of 4.2% per year.

Key information

-7.8%

Earnings growth rate

18.1%

EPS growth rate

Healthcare Services Industry Growth42.6%
Revenue growth rate-4.2%
Return on equity-154.0%
Net Margin-375.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Intelicare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:ICR Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-120
30 Sep 230-220
30 Jun 230-320
31 Mar 230-420
31 Dec 220-420
30 Sep 220-420
30 Jun 220-420
31 Mar 220-430
31 Dec 210-530
30 Sep 210-530
30 Jun 210-430
31 Mar 210-320
31 Dec 201-210
30 Sep 200-210
30 Jun 200-310
30 Jun 190001
30 Jun 180000

Quality Earnings: ICR is currently unprofitable.

Growing Profit Margin: ICR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ICR is unprofitable, and losses have increased over the past 5 years at a rate of 7.8% per year.

Accelerating Growth: Unable to compare ICR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ICR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (14.3%).


Return on Equity

High ROE: ICR has a negative Return on Equity (-153.99%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.